抗精神病剂量,多巴胺D2受体占用率和额外皮拉米德副作用:系统性审查和剂量反应元分析
Spyridon Siafis1, Hui Wu2, Dongfang Wang2
1Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany. spyridon.siafis@tum.de.
Molecular psychiatry
|August 3, 2023
概括
抗精神病药物剂量显著影响额外皮拉米德级副作用 (EPS) 风险,大多数药物显示剂量依赖的增加. 奎蒂亚平和塞尔多尔是例外,在所有剂量中具有可以忽略的EPS风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 抗精神病药物对于精神分裂症的治疗至关重要,但它们引起外皮拉米德性副作用 (EPS) 的倾向有所不同.
- 了解这些副作用的剂量反应关系对于优化治疗和患者安全至关重要.
结论:
- 随着抗精神病剂量增加,EPS的风险会升级,在药物类别之间存在显著差异.
- 多巴胺D2受体占用率超过75-85%,与显著的EPS风险相关,除了部分激动剂.
- 结果提供了对D2R治疗窗口的见解,以尽量减少精神分裂症治疗中的EPS.
相关概念视频
Antipsychotic Drugs: Typical and Atypical Agents
249
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
249
Antipsychotic Drugs: Therapeutic Uses and Side Effects
261
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
261
Dose-Response Relationship: Overview
3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
Psychosis and Antipsychotic Drugs: Overview
328
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
328
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
396
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
396


